SPOTLIGHT -
Aligning Contracting to Solve for Payer Risks Is a Win for Biopharma, Payers, and Patients
Upcoming regulatory changes to create new opportunity for specialized offerings.
Improving Management of Gene and Cell Therapies
An overview of Orphan Reinsurer and Benefit Managers groups, including potential challenges with the model and various model suggestions.